PHARMACY

Lupin receives FDA green light for generic Hectorol

BY Sandra Levy

Lupin has garnered the Food and Drug Administration’s clearance for doxercalciferol injection,in 4 mcg/2 mL (2 mcg/mL) multi-dose vials.

The product, which is a generic version of Sanofi Genzyme’s Hectorol injection is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

Doxercalciferol injection had a market value of approximately $133 million, according to September 2018 IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer